|Articles|June 5, 2017

Zika Virus Successfully Diagnosed From Semen

Research presented at ASM Microbe 2017 by experts at the Fertility and Cryogenics Lab shows a reliable clinical assay that can detect the Zika virus from semen samples.

"This assay can help reduce Zika infection rates and allow couples who are identified at risk due to travel or geographic location plan their pregnancy," said lead author Hisham Greiss MD, PhD, HCLD, at the Fertility and Cryogenics Lab.

A total of 100 semen samples were spiked with a recombinant Accuplex ZIKV (SeraCare Life Sciences) at five viral copies per ml and processed in Aptima Urine Transport medium (Hologic Inc.) and tested using Aptima® ZIKV assay released under the FDA's emergency use authorization on the fully automated Panther system from Hologic, Inc. The samples were also tested for West Nile Virus, Chagas and Dengue, recombinant Dengue Virus, recombinant Chikungunya Virus, Human Papilloma Virus, Herpes Simplex Virus 1, Herpes Simplex Virus 2, Chlamydia, and Gonorrhea. The experiment was repeated three times and in triplicates each time.

The assay was found to be 100 percent sensitive and 100 percent specific to ZIKV RNA from semen samples with a limit of detection of five viral copies per mL of semen.

Zika fever symptoms are often misdiagnosed due to its nonspecific clinical symptoms, so an accurate diagnosis is of paramount importance for management of the disease and to prevent neonatal infections. Zika infection during pregnancy can also cause serious birth defects and is associated with other pregnancy problems.

Source: American Society for Microbiology
 




Related to this article

Water  (Adobe Stock 456102510 by stockphoto-graf)
Understanding current water quality is a starting point for ST108 implementation. John Kimsey, vice president of processing optimization and customer success for STERISS, spoke about his HSPA presentation on assessing readiness, distinguishing system qualification from routine testing, and understanding where water samples should be collected.
Image of Pathogens flying   (Adobe Stock weerasak)
Behind every landmark in infection prevention, from antimicrobial stewardship guidelines to the COVID-19 town halls that reached flight attendants and teachers, is a generation of physician-scientists who led SHEA through crises, organizational change, and scientific breakthroughs. Infection Control Today traces 30 years of SHEA presidents and the lasting mark they left on the field.
AORN26 New Orleans 2026  (Adobe Stock)
Missing instruments and processing delays can strain OR–SPD relationships. At AORN 2026, John Kimsey, vice president of processing optimization and customer success for STERIS, discusses understanding root causes, exploring off-site reprocessing for ambulatory surgical centers, and using hands-on simulation to help surgical teams see sterile processing from a different perspective.